Ho Jong Chun

2.6k total citations
118 papers, 1.9k citations indexed

About

Ho Jong Chun is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Ho Jong Chun has authored 118 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Surgery, 55 papers in Pulmonary and Respiratory Medicine and 52 papers in Hepatology. Recurrent topics in Ho Jong Chun's work include Hepatocellular Carcinoma Treatment and Prognosis (43 papers), Liver Disease and Transplantation (19 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers). Ho Jong Chun is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (43 papers), Liver Disease and Transplantation (19 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers). Ho Jong Chun collaborates with scholars based in South Korea, United States and United Kingdom. Ho Jong Chun's co-authors include Hae Giu Lee, Jae Young Byun, Byung Gil Choi, Sung Eun Rha, Si Hyun Bae, Seung Kew Yoon, Seung Eun Jung, Jae Mun Lee, Jong Young Choi and Jung Suk Oh and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Radiology.

In The Last Decade

Ho Jong Chun

111 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ho Jong Chun South Korea 24 964 806 606 463 210 118 1.9k
Young So South Korea 26 774 0.8× 487 0.6× 641 1.1× 414 0.9× 116 0.6× 111 2.2k
Tetsuo Sonomura Japan 19 790 0.8× 579 0.7× 545 0.9× 319 0.7× 90 0.4× 154 1.5k
Magaly Zappa France 24 711 0.7× 740 0.9× 253 0.4× 921 2.0× 283 1.3× 69 2.0k
Sung Wook Shin South Korea 28 1.4k 1.4× 837 1.0× 746 1.2× 449 1.0× 586 2.8× 100 2.4k
James G. Caridi United States 20 1.2k 1.2× 1.2k 1.5× 722 1.2× 611 1.3× 115 0.5× 54 2.2k
Sam Heye Belgium 25 852 0.9× 408 0.5× 1.0k 1.7× 438 0.9× 219 1.0× 104 2.1k
Naoyuki Toyota Japan 23 1.1k 1.2× 495 0.6× 543 0.9× 371 0.8× 49 0.2× 102 1.7k
Hae Giu Lee South Korea 16 418 0.4× 370 0.5× 372 0.6× 181 0.4× 204 1.0× 47 1.1k
Jae Kyu Kim South Korea 16 646 0.7× 327 0.4× 728 1.2× 365 0.8× 136 0.6× 65 1.6k
Do Yun Lee South Korea 22 755 0.8× 745 0.9× 705 1.2× 286 0.6× 34 0.2× 92 1.7k

Countries citing papers authored by Ho Jong Chun

Since Specialization
Citations

This map shows the geographic impact of Ho Jong Chun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho Jong Chun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho Jong Chun more than expected).

Fields of papers citing papers by Ho Jong Chun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho Jong Chun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho Jong Chun. The network helps show where Ho Jong Chun may publish in the future.

Co-authorship network of co-authors of Ho Jong Chun

This figure shows the co-authorship network connecting the top 25 collaborators of Ho Jong Chun. A scholar is included among the top collaborators of Ho Jong Chun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho Jong Chun. Ho Jong Chun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Bohyun, Seok Hyun Son, Jeong Won Jang, et al.. (2025). Evaluation of the LI-RADS radiation treatment response assessment v2024 in comparison with the modified RECIST. European Radiology. 35(12). 7549–7559.
2.
Kim, Ji Hong, Young Il Kim, Heechul Nam, et al.. (2024). Consistent efficacy of hepatic artery infusion chemotherapy irrespective of PD‑L1 positivity in unresectable hepatocellular carcinoma. Oncology Letters. 28(2). 388–388. 1 indexed citations
3.
Kim, Myung Sub, Jung Suk Oh, Ho Jong Chun, Su Ho Kim, & Byung Gil Choi. (2024). Comparison of Small-Sized (70–150 μm) and Intermediate-Sized (100–300 μm) Drug-Eluting Embolics for Transarterial Chemoembolization of Small Hepatocellular Carcinomas (≤3 cm). Journal of Vascular and Interventional Radiology. 35(11). 1626–1634.e3. 1 indexed citations
4.
Chun, Ho Jong, et al.. (2024). TACE vs. TARE for HCC ≥ 8 cm: A propensity score analysis. Abdominal Radiology. 50(3). 1198–1208. 4 indexed citations
5.
Lee, Byung-Chan, Gyoung Min Kim, Jin Wook Chung, et al.. (2024). Comparison of Chemoembolization Outcomes Using 70–150 µm and 100–300 µm Drug-Eluting Beads in Treating Small Hepatocellular Carcinoma: A Korean Multicenter Study. Korean Journal of Radiology. 25(8). 715–715. 1 indexed citations
6.
Oh, Jung Suk, et al.. (2023). Incidence and Risk Factors of Acute Ischemic Cholecystitis after Transarterial Chemoembolization: Correlation with Cone Beam CT Findings. SHILAP Revista de lepidopterología. 85(2). 363–363. 1 indexed citations
10.
Chun, Ho Jong, et al.. (2022). Economics of drug‐coated balloons for arteriovenous fistula stenosis in Japan and Korea based on the IN.PACT AV access trial. Nephrology. 27(11). 859–868. 4 indexed citations
11.
Lee, Jaejun, Hyun Yang, Chang Ho Jeon, et al.. (2022). Multidisciplinary treatment with immune checkpoint inhibitors for advanced stage hepatocellular carcinoma. SHILAP Revista de lepidopterología. 22(1). 75–83. 4 indexed citations
12.
Lee, Myungsu, Jin Wook Chung, Kwang-Hun Lee, et al.. (2021). Prospective Multi-Center Korean Registry of Transcatheter Arterial Chemoembolization with Drug-Eluting Embolics for Nodular Hepatocellular Carcinoma: A Two-Year Outcome Analysis. Korean Journal of Radiology. 22(10). 1658–1658. 7 indexed citations
15.
Yang, Keungmo, Pil Soo Sung, Jung Suk Oh, et al.. (2019). Pathologic complete response to chemoembolization improves survival outcomes after curative surgery for hepatocellular carcinoma: predictive factors of response. HPB. 21(12). 1718–1726. 15 indexed citations
16.
Lee, Hae Giu, et al.. (2018). Extraluminal Recanalization of Bile Duct Anastomosis Obstruction after Liver Transplantation. Journal of Vascular and Interventional Radiology. 29(10). 1466–1471. 8 indexed citations
17.
Kim, Su Ho, Jung Suk Oh, Ho Jong Chun, Byung Gil Choi, & Hae Giu Lee. (2018). Dual-Port versus Mono-Port Implantation for Intra-Arterial Chemoinfusion Therapy for Treatment of Hepatocellular Carcinoma in Patients with Anatomic Hepatic Artery Variation. Journal of Vascular and Interventional Radiology. 30(1). 23–30. 5 indexed citations
18.
Song, Myeong Jun, Si Hyun Bae, Ie Ryung Yoo, et al.. (2012). Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.. PubMed. 18(25). 3215–22. 38 indexed citations
19.
Jang, Jeong Won, Si Hyun Bae, Jong Young Choi, et al.. (2006). A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management. Cancer Chemotherapy and Pharmacology. 59(1). 9–15. 30 indexed citations
20.
Jung, Joon‐Yong, et al.. (2005). Adhesive capsulitis of the shoulder: evaluation with MR arthrography. European Radiology. 16(4). 791–796. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026